University Hospitals Coventry and Warwickshire
Hospital
Location:
Coventry,
United Kingdom (GB)
ISNI: 0000000404005079
ROR: https://ror.org/025n38288
Show on Map:
Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECAST (2021)
Srirajaskanthan R, Pavel ME, Kulke M, Clement D, Houchard A, Keeber L, Weickert MO
Journal article
Development and validation of the SIMPLE endoscopic classification of diminutive and small colorectal polyps (2018)
Iacucci M, Trovato C, Daperno M, Akinola O, Greenwald D, Gross SA, Hoffman A, et al.
Journal article
Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome (2018)
Weickert MO, Kaltsas G, Hoersch D, Lapuerta P, Pavel ME, Valle JW, Caplin ME, et al.
Journal article
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial (2018)
Pavel ME, Gross DJ, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, et al.
Journal article
Weight Change Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome (2018)
Weickert MO, Kaltsas G, Hoersch D, Lapuerta P, Pavel ME, Valle JW, Caplin ME, et al.
Journal article